KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Repligen (RGEN) EBITDA (2016 - 2025)

Historic EBITDA for Repligen (RGEN) over the last 16 years, with Q3 2025 value amounting to $12.5 million.

  • Repligen's EBITDA rose 3656.2% to $12.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.3 million, marking a year-over-year increase of 487746.91%. This contributed to the annual value of -$40.2 million for FY2024, which is 22503.57% down from last year.
  • Repligen's EBITDA amounted to $12.5 million in Q3 2025, which was up 3656.2% from $61.0 million recorded in Q2 2025.
  • In the past 5 years, Repligen's EBITDA registered a high of $69.6 million during Q4 2022, and its lowest value of -$51.8 million during Q4 2024.
  • Moreover, its 5-year median value for EBITDA was $18.3 million (2023), whereas its average is $18.6 million.
  • As far as peak fluctuations go, Repligen's EBITDA plummeted by 37538.56% in 2024, and later skyrocketed by 134871.73% in 2025.
  • Quarter analysis of 5 years shows Repligen's EBITDA stood at $22.1 million in 2021, then soared by 214.3% to $69.6 million in 2022, then crashed by 115.65% to -$10.9 million in 2023, then plummeted by 375.39% to -$51.8 million in 2024, then surged by 124.18% to $12.5 million in 2025.
  • Its EBITDA stands at $12.5 million for Q3 2025, versus $61.0 million for Q2 2025 and $10.5 million for Q1 2025.